[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 71 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 71
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 9, 2023
Mr. Biggs introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to exempt from
regulation as devices non-invasive diagnostic devices, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Medical Innovation Acceleration Act
of 2023''.
SEC. 2. EXEMPTING NON-INVASIVE DIAGNOSTIC DEVICES FROM REGULATION AS
DEVICES.
Section 201(h) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 321(h)) is amended--
(1) by striking ``section 520(o)'' and inserting the
following: ``section 520(o) or any non-invasive diagnostic
device''; and
(2) by adding at the end the following: ``For purposes of
the preceding sentence, the term `non-invasive' means, with
respect to a diagnostic device, that the device does not
penetrate the skin or any other membrane of the body, is not
inserted or implanted into the body, causes no more than
ephemeral compression or temperature changes to in situ bodily
tissues, and does not subject bodily tissues to ionizing
radiation.''.
<all>